Pdf bisphosphonate related osteonecrosis of the jaws. Bisphosphonate use in cancer patients is associated with osteonecrosis of the jaws bisphosphonate induced osteonecrosis of the jaws bionj. Endodontic implications of bisphosphonateassociated. Department of oral and maxillofacial radiology and research institute of oral science, college of dentistry, gangneungwonju national university, gangneung, korea.
The change is justified to accommodate the growing number of osteonecrosis. Bisphosphonaterelated osteonecrosis of the jaw scielo. The site of occurrence of the osteonecrosis is the jaws, and presentation occurs more frequently in the mandible than in the maxilla. Department of oral and maxillofacial radiology and research institute of oral science, college of dentistry, gangneungwonju national university. In 2002, the food and drug administration fda received first reports related to several patients with cancer, treated with the iv bisphosphonates bp, who developed osteonecrosis of the jaw. Bisphosphonateassociated osteonecrosis of the jaw the.
Jan 11, 20 the prolonged use of bisphosphonates has been shown to cause a condition termed bisphosphonate related osteonecrosis of the jaws bronj. Since intravenous administration leads to a higher drug exposure than the oral route, osteonecrosis related to oral bisphosphonate therapy is less common than that of related to intravenous forms such as zolendronate which is also more potent than oral bisphosphonates. This case presentation focuses on a 50yearold woman with a 10year history of monthly zometa zoledronic acid use for treatment of multiple myeloma, resulting in bronj with a very unfavorable outcome. The aim of this study was to evaluate image characteristics of bisphosphonaterelated osteonecrosis of the jaws bronj and compare these with osteoradionecrosis orn. Oral bisphosphonates and the risk for osteonecrosis of the. Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate induced osteonecrosis of the jaw. Osteonecrosis of jaws onj might be old, dating back a century in the form of phossy jaw.
Osteonecrosis of the jaw a potencial adverse effect of bisphosphonate treatment. Advisory task force on bisphosphonate related ostenonecrosis of the jaws. American association of oral and maxillofacial surgeons. Pdf bisphosphonaterelated osteonecrosis of the jaw. Pdf bisphonates are used widely to treat osteoporosis, hyperglycemia of malignancy, bone metastasis of solid tumors. Medicationrelated osteonecrosis of the jaw in patients with. Bisphosphonaterelated osteonecrosis of the jaws request pdf. Osteonecrosis of the jaw in patients treated with bisphosphonates is a relatively rare but well known complication at maxillofacial units around the world. Bisphosphonaterelated osteonecrosis of the jaws bronj is a severe complication seen most frequently in patients on intravenous bisphosphonates treatment for malignant diseases.
Task force on bisphosphonaterelated osteonecrosis of the jaws. Early surgical laserassisted management of bisphosphonate. A mycotic infestation has been found in all of the 18 cases studied. This study tested hyperbaric oxygen hbo as an adjunct to surgery and antibiotics in the treatment of bisphosphonate related osteonecrosis of the jaw onj and evaluated its effects.
Bisphosphonate associated osteonecrosis of the jaw is an important condition seen most commonly in oncology patients receiving highdose intravenous bisphosphonates. Bisphosphonaterelated osteonecrosis of the jaws bronj core. Endodontic implications of bisphosphonate associated osteonecrosis of the jaws the guidance in this statement is not intended to substitute for a clinicians independent judgment in light of. Bisphosphonates are frequently used worldwide mostly in osteoporosis and skeletal bone metastases. In this article, we report two new cases of patients. An update on bisphosphonaterelated osteonecrosis of the jaw. One centres on the bisphosphonate induced osteoclast inhibition and the other explains the process in terms of antiangiogenic mechanisms 2. Two broad theories have been articulated to explain the pathogenesis if bisphosphonate related osteonecrosis of the jaws bronj. Incidence of bisphosphonate related osteonecrosis of the jaws bronj in patients taking bisphosphonates for osteoporosis treatmenta grossly underestimated risk.
Usefulness of dwi in mri diagnosis of bisphosphonate related. Oral bisphosphonate related osteonecrosis of jaws bronj. The american college of prosthodontists agrees with the recommendation for the term, medicationrelated osteonecrosis of the jaw mronj suggested by the american association of maxillofacial surgeons aaoms to replace the previous, morespecific term, bisphosphonaterelated. Bisphosphonaterelated osteonecrosis of the jaws onj. Bisphosphonates bps are a class of drugs used to treat osteoporosis and malignant bone metastasis. Bps antiresorptive activity substantially reduce fracture risk by 40%70% in osteoporosis patients, and improve quality of life in cancer patients by preventing skeletal complications. Bisphosphonatesrelated osteonecrosis of the jaw bronj. As a rheumatologist who has seen and managed bisphosphonate related osteonecrosis of the jaws fung e, medwatch case reports. In most cases the development of onj in those taking. Drug related risk factors a bisphosphonate potency.
Bisphosphonates and osteonecrosis of the jaw bisphosphonate medications are linked to a risk of osteonecrosis of the jaw. The special committee favors the term medication related osteonecrosis of the jaw mronj. Because these drugs have become more prevalent, there have been increased reports of bisphosphonaterelated osteonecrosis of the jaws bronj. Osteonecrosis of the jaws onj, also called antiresorptive agentinduced osteonecrosis of the jaw aronj and medicationrelated osteonecrosis of the jaw, is an oral complication in patients receiving bisphosphonate or rankl inhibitor therapy.
However, there is limited scientific understanding about the association between osteonecrosis of the jaws and bisphosphonates. Osteonecrosis of the jaw an overview sciencedirect topics. Although the methods of action are not yet completely understood, it is hypothesized that medicationassociated osteonecrosis of the jaw is related to a defect in jaw bone healing and remodelling. Lowdose bisphosphonates given either orally or intravenously in osteoporosis patients have not been causally linked to the development of osteonecrosis of the jaw. Reports of bisphosphonate related osteonecrosis of the jaw bronj were recognized as early as 2003. In cancer patients bionj occurs mainly with long term, potent high dose intravenous bisphosphonates with an incident rate of 35%. American association of oral and maxillofacial surgeons position paper on bisphosphonaterelated osteonecrosis of the jaws. A bibliographic search in medline, pubmed and the cochrane register of controlled clinical trials was performed between 2003 and 2010 by using the terms bisphosphonate and osteonecrosis of the jaw.
Bisphosphonaterelated osteonecrosis of the jaws bronj is an extremely therapy. Condition bisphosphonates, like alendronate fosamax, description care management tips osteonecrosis of the jaw onj is a condition where the jawbone is exposed and not. A side effect called osteonecrosis of the jaw onj bone damage in the jaw has been reported uncommonly in patients receiving zoledronic acid zometa injections for cancer related. Pdf bisphosphonaterelated osteonecrosis of the jaw bronj is a dramatic disintegration of the jaw that affects patients treated with. Bisphosphonateassociated osteonecrosis of the jaw is an important condition seen most commonly in oncology patients receiving highdose intravenous bisphosphonates.
The special committee favors the term medicationrelated osteonecrosis of the jaw mronj. Bisphosphonaterelated osteonecrosis of the jaw in patients with. In this article, bisphosphonate associated osteonecrosis or bon will be the terms used to describe an osteonecrosis of the jaws secondary to bisphosphonate therapy. Bisphosphonaterelated osteonecrosis of the jaws bronj. It has been speculated that the medication, especially longterm i. Oral bisphosphonates are the most commonly prescribed antiresorptive drugs for the treatment of osteoporosis. The american association of oral and maxillofacial. One of the serious adverse effects of bisphosphonate therapy is bisphosphonaterelated osteonecrosis of the jaw bronj. Pdf bisphosphonaterelated osteonecrosis of the jaws. The following protocols have been developed by the bc cancer agency department of oral oncology. There is no test to measure onj risk, but some factors are known to raise this risk in very rare. Its pathogenesis is not well understood and its management is difficult. Possible association between diabetes and bisphosphonate.
In this group of selected patients with recurrent lithiasis and osteopenia the treatment with. Research article image findings of bisphosphonate related. Tosi p, zamagni e, cangini d, tacchetti p, offidani m, ronconi s, et al. Twenty caucasian patients 19 women and 1 man were identified with a total of 24 lesions that satisfied the. Osteonecrosis of the jaw is a serious complication associated with oral and intravenous bisphosphonate therapy. Position paper on bisphosphonaterelated osteonecrosis of the jaw2009 update. Oral bisphosphonate related osteonecrosis of the jaw. Osteonecrosis of the jaw onj is a rare dental condition. Dental care protocols bisphosphonate medications are linked to a risk of osteonecrosis of the jaw. One problem in identifying cases of bonj is that there is no universal agreement on a definition of the condition, compounded by the many terms used to describe it. The management of bisphosphonaterelated osteonecrosis of the jaws bronj is emerging as a significant problem in the field of dentistry. Bisphosphonaterelated osteonecrosis of the jawsa case.
In this article, we report two new cases of patients with. Bisphosphonaterelated osteonecrosis of the jaws bronj is an extremely therapy resistant osteomyelitislike disease exclusively involving the jaw bones of patients in treatment with bisphosphonates bps. Bisphosphonaterelated osteonecrosis of the jaws bronj presents the clinician with significant management dilemmas. An identification of the fungal agent and its incrimination in the pathogenesis of bisphosphonates related osteonecrosis of the jaw. Additional important issues related to bisphosphonateassociated onj include. Bisphosphonaterelated osteonecrosis of the jaw bone. American association of oral and maxillofacial surgeons american association of oral and maxillofacial surgeons position paper on bisphosphonaterelated osteonecrosis of the jaws 2009 update.
Bisphosphonate dental care protocol bisphosphonates and osteonecrosis of the jaw. The incidence and susceptibility factors in cases of bisphosphonateinduced osteonecrosis of the jaw have been studied in patients with breast cancer and gynecological malignancies 16c. Imaging findings of bisphosphonateassociated osteonecrosis. Osteonecrosis of the jaws is recognized as a serious complication of bisphosphonate therapy, more commonly with the intravenous form of the drugs. Bisphosphonaterelated osteonecrosis of the jaw in patients with osteoporosis. Medication related osteonecrosis of the jaw guidance for the oncology multidisciplinary team 6 mronj in the adjuvant setting the frequency of mronj from oral bisphosphonates in the early breast cancer setting is 0. Bisphosphonaterelated osteonecrosis of the jaws rev bras reumatol 2011. Bronj is a disease entity which has only been described relatively recently, and its multi. However, prolonged bp use is associated with a significant dental complication termed bisphosphonaterelated osteonecrosis of the jaw bronj. The objective of the study was to evaluate whether diabetes mellitus dm may be a contributing factor in the development of bon.
Bisphosphonate related osteonecrosis of the jaw onj is characterized by nonhealing exposed bone in the maxillofacial region in patients who have undergone bisphosphonate treatment. Bisphosphonaterelated osteonecrosis bon of the jaws is a newly identified condition for which the exact mechanism involved in its pathogenesis remains obscure. Surgical management of bisphosphonate related osteonecrosis of the jaws bronj has been performed in an attempt to increase healing rates of the affected cases. Oral bisphosphonaterelated osteonecrosis of the jaws. Page 1 medicationrelated osteonecrosis of the jaw 2014 update. Survey of korean dentists on the awareness on bisphosphonate. We investigated the ct and dental panoramic radiograph dpr images for osteolysis. Approved by the board of trustees, september 25, 2006. This phenomenon, first observed after infusion of potent, nitrogencontaining bps for treating multiple myeloma and cancers involving bone metastasis, was termed bisphosphonaterelated osteonecrosis of the jaws. The change is justified to accommodate the growing number of osteonecrosis cases involving the maxilla and mandible associated with other antiresorptive denosumab. Bisphosphonate related osteonecrosis of the jaws the. Although this complication has also been reported in patients receiving antiresorptive agents for. Medicationrelated osteonecrosis of the jaw wikipedia. Bisphosphonaterelated osteonecrosis of the jaws bronj is among the most serious ones.
Both try to address the predilection for this occurrence in the jaws. Bisphosphonates, drugs that decrease bone turnover by inhibiting osteoclastmediated bone resorption, are used to treat osteoporosis, paget disease, pain from osseous metastases, and malignancyrelated hypercalcemia. Legal liability from the perspective of the prescribing physician. The restriction of bisphosphonate induced osteonecrosis to the jaw is thought to be related to the unique nature of the blood supply, structure, function and microbiology of the jaw bones adamo et al. From the molecular viewpoint, bps are postulated to modulate the function of osteoclasts, reacting with a surface. Harper and fung1, i wish to comment and raise questions on the recent. Bisphosphonate related osteonecrosis of the jaw rev bras reumatol 2012. Harper and fung1, i wish to comment and raise questions on the recent editorial by kahn2 and article by etminan, et al 3. However, there are several adverse effects associated with oral bisphosphonates including the bisphosphonate related osteonecrosis of the jaw bronj. A bibliographic search in medline, pubmed and the cochrane register of controlled. Bisphosphonate related osteonecrosis of the jaw bronj can adversely affect quality of life, as it may produce significant morbidity. Current or previous treatment with a bisphosphonate. The restriction of bisphosphonate induced osteonecrosis to the jaw is thought to be related to the unique nature of the blood supply, structure, function and microbiology of the jaw.
The paget foundation for pagets disease of bone and related. Vescovi p, manfredi m, merigo e, guidotti r, meleti m, pedrazzi g, fornaini c, bonanini m, ferri t, nammour s 2012 early surgical laserassisted management of bisphosphonaterelated osteonecrosis of the jaws bronj. The condition is predominantly confined within the maxillofacial region. Bisphosphonates are a class of agents whose efficacy in treating and preventing the skeletal complications associated with osteoporosis and malignant bone metastases has been well established. Bps show high binding capacity to the bone matrix, especially in sites of active bone metabolism. Bisphosphonate related osteonecrosis of the jaws bronj is mainly observed in patients with multiple myeloma and bone metastasis from solid tumors receiving iv bisphosphonate. Guidelines for the diagnosis of bisphosphonaterelated. Apr 20, 2020 american association of oral and maxillofacial surgeons position paper on bisphosphonaterelated osteonecrosis of the jaws. Medication related osteonecrosis of the jaw mronj, which was first described in 2002, is a relatively uncommon but potentially serious side effect of treatment with osteoclast inhibitors, such as intravenous highpotency bisphosphonates and denosumab, which decrease the risk of skeletal related events in patients with cancer and metastatic bone disease. Bisphosphonates and osteonecrosis of the jaws journal of. The reasons for the presentation of osteonecrosis in the jaws versus other parts of the skeleton are unknown at this time. Condition bisphosphonates, like alendronate fosamax, description care management tips osteonecrosis of the jaw onj is a condition where the jawbone is exposed and not covered by gums. In 2003, bisphosphonaterelated osteonecrosis of the jaw bronj was first reported, with the demonstration of 36 bone lesions of the mandible andor maxilla in. Diagnostic tissue sampling may exacerbate the process and is.
Pdf incidence of bisphosphonaterelated osteonecrosis of. Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate induced osteonecrosis of the jaw in a patient with multiple myeloma. Bisphosphonate related osteonecrosis of the jaw bronj is defined as exposed necrotic bone appearing in the jaws of patients treated by systemic iv or oral bps never irradiated in the head and neck area and that has persisted for more than 8 weeks. Experience with treating osteonecrosis of the jaw patients and recording medication histories were significantly greater in dental hospitals with 300 beds or university hospitals. Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonateinduced osteonecrosis of the jaw in a patient with multiple myeloma. Bisphosphonates are potent inhibitors of bone resorption, and are used in the treatment of osteoporosis and other diseases that cause bone mass loss, such as. Utility of preoperative imaging diagnosis for a malignant tumor of the mandible. Bisphosphonate associated osteonecrosis of the jaw. Medicationrelated osteonecrosis of the jaw2014 update. Jan 04, 2012 surgical management of bisphosphonaterelated osteonecrosis of the jaws. The underlying etiology is unclear and may be multifactorial. Despite these benefits, osteonecrosis of the jaws has recently emerged as a significant. However, there are several adverse effects associated with oral bisphosphonates including the bisphosphonate related osteonecrosis of the jaw.
1177 114 308 786 284 967 1441 1250 1463 1141 809 483 1533 1421 717 581 1234 809 55 198 509 449 231 707 738 8 141 374 1230 606 816 668 1292 276 770